Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Open: Sep 2, 12:50 PM 2010 
  NYSE  6936.34  25.36  Index Moved Up   NASDAQ  2191.06  14.22  Index Moved Up 
 { and more.. }
Search is sponsered by  
  



Processing
Collecting necessary data for SLXP and USNA...

    
SLXP  Salix Pharmaceuticals Ltd.  vs  USNA  USANA Health Sciences Inc.
    

   ProfileMedia
39.6
  
Salix Quote
Intraday
 
Salix Intraday Quote
One Month
 0.50   Macroaxis: 1.28 Up   1.28%  
Salix Quote: BullSLXP Macroaxis: United States NASDAQ
Salix Pharmaceuticals Ltd.
 
Market Cap 2.290B   Book Value 6.472   EBITDA -12.0M   PEG Ratio 29.94   EPS -1.178   P/B Ratio 6.04   Short Ratio 6.50   Index Membership S&P   Sector Healthcare   Full Time Employees 395   Profile Get Profile for:   Drug Related Products   Open 39.06   High 39.6397   Low 38.98   Volume 196.7 K   Target Price 50.60   Current EPS -1.178   This Year EPS 0.03   Next Year EPS 1.55   This Year PE 1303.33   Next Year PE 25.23  
    
    
    
Symbol  SLXP
Name  Salix Pharmaceuticals Ltd.
TypeStock
Country  Macroaxis: United States United States
Exchange  NASDAQ
 
Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States.
    

Company Summary   more 

    
Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or shor...
Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or short-term therapy for adults; Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis; Anusol-HC and Proctocort, the hydrocortisone creams and suppositories for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and inflammatory conditions; Pepcid and Diuril oral suspensions, which are used for gastrointestinal indications that include the treatment of duodenal ulcer, benign gastric ulcer, and gastro esophageal reflux diseases; and Colazal capsules for the treatment of ulcerative colitis. In addition, Salix has products under development for the treatment of hepatic encephalopathy and irritable bowel syndrome, HIV-associated diarrhea, gastroenterology, and ulcerative proctitis or proctosigmoiditis. It has collaboration agreements with aaiPharma LLC; Alfa Wassermann S.P.A.; Biorex Laboratories Limited; Cedars?Sinai Medical Center; Clinical Development Capital Partnership; Dr. Falk Pharma GmbH; King Pharmaceuticals, Inc.; Lupin, Ltd.; Merck & Co., Inc.; Napo Pharmaceuticals, Inc.; Norgine B.V.; and Wilmington Pharmaceuticals, LLC. The company was founded in 1989 and is headquartered in Morrisville, North Carolina.
Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The company?s marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers? diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also include Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or shor...
    

Top Stories

 
 
 
 
 

Community Discussions

        
  
42.5
  
USANA Quote
Intraday
 
USANA Intraday Quote
One Month
(0.50)  Macroaxis: -1.16 Down   1.16%  
USANA Quote: BearUSNA Macroaxis: United States NASDAQ
USANA Health Sciences Inc.
 
Market Cap 651.2M   Book Value 6.434   EBITDA 65.9M   PEG Ratio 0.92   EPS 2.479   P/E 17.35   P/B Ratio 6.68   Short Ratio 15.50   Sector Healthcare   Full Time Employees 930   Profile Get Profile for:   Drug Related Products   Open 42.91   High 43.00   Low 42.44   Volume 4.2 K   Target Price 46.00   Current EPS 2.479   This Year EPS 2.72   Next Year EPS 3.06   Current PE 17.35   This Year PE 15.81   Next Year PE 14.05  
    
    
    
Symbol  USNA
Name  USANA Health Sciences Inc.
TypeStock
Country  Macroaxis: United States United States
Exchange  NASDAQ
 
USANA Health Sciences, Inc. engages in the development, manufacture, and sale of nutritional and personal care products in North America and the Asia Pacific.
    

Company Summary   more 

    
USANA Health Sciences, Inc. engages in the development, manufacture, and sale of nutritional and personal care products in North America and the Asia Pacific. The company offers two product lines, USANA Nutritionals and Sense. The USANA Nutritionals product line consists of essentials, which include vitamins and mineral supplements that provide a foundation of nutrition for various age groups; optimizers, which are targeted supplements that support cardiovascular health, skeletal/structural health, and digestive health; and macro-optimizers comprising low-glycemic meal replacement shakes, snack bars, and other related products that provide optimal macro-nutrition. The Sense product line incl...
USANA Health Sciences, Inc. engages in the development, manufacture, and sale of nutritional and personal care products in North America and the Asia Pacific. The company offers two product lines, USANA Nutritionals and Sense. The USANA Nutritionals product line consists of essentials, which include vitamins and mineral supplements that provide a foundation of nutrition for various age groups; optimizers, which are targeted supplements that support cardiovascular health, skeletal/structural health, and digestive health; and macro-optimizers comprising low-glycemic meal replacement shakes, snack bars, and other related products that provide optimal macro-nutrition. The Sense product line includes personal care products that support healthy skin and hair. These products include perfecting essence, gentle daily cleanser, hydrating toner, daytime protective emulsion, eye nourisher, night renewal, serum intensive, rice bran polisher, creme masque, revitalizing shampoo, nourishing conditioner, firming body nourisher, energizing shower gel, and intensive hand therapy. USANA Health Sciences also develops and sells resource materials and sales tools, including product brochures and business forms; reprints of other commercial publications; and contracts with authors and publishers to produce or provide books, tapes, and other items that deal with health topics and personal motivation to assist its associates. The company distributes its products through a network marketing system of organized independent distributors. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
USANA Health Sciences, Inc. engages in the development, manufacture, and sale of nutritional and personal care products in North America and the Asia Pacific. The company offers two product lines, USANA Nutritionals and Sense. The USANA Nutritionals product line consists of essentials, which include vitamins and mineral supplements that provide a foundation of nutrition for various age groups; optimizers, which are targeted supplements that support cardiovascular health, skeletal/structural health, and digestive health; and macro-optimizers comprising low-glycemic meal replacement shakes, snack bars, and other related products that provide optimal macro-nutrition. The Sense product line incl...
    

Top Stories

 
 
 
 

Community Discussions